Natalee PIII trial demonstrates ribociclib reduces the risk of breast cancer
27 Mar 2023 //
GLOBENEWSWIRE
TRIO Enrols 1st Patient in Global PIII Giredestrant Early Breast Cancer Trial
31 Aug 2021 //
GLOBENEWSWIRE
27 Mar 2023 //
GLOBENEWSWIRE
31 Aug 2021 //
GLOBENEWSWIRE